관류 바이오리액터 시장 규모, 점유율 및 동향 분석 보고서 : 유형별, 용도별, 최종 용도별, 지역별 및 부문별 예측(2026-2033년)

Perfusion Bioreactors Market Summary

The global perfusion bioreactors market size was valued at USD 430.5 million in 2025 and is anticipated to reach USD 839.8 million by 2033, growing at a CAGR of 8.9% from 2026 to 2033. This growth is primarily driven by increasing demand for high-yield, continuous bioprocessing in biopharmaceutical manufacturing, rising production of monoclonal antibodies, vaccines, and recombinant proteins, and the expanding pipeline of cell and gene therapies.

Global Perfusion Bioreactors Market Report Segmentation

This report forecasts revenue growth at the global, regional and country levels and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global perfusion bioreactors market report on the basis of type, application, end use, and region.

• Type Outlook (Revenue, USD Million, 2021 - 2033)
• Small Scale Perfusion Bioreactors
• Large Scale Perfusion Bioreactors
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Biopharmaceutical Production
• Tissue Engineering
• Stem Cell Research
• Others
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Biopharmaceutical Companies
• Academic and Research Institutes
• CROs & CMOs
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Market Definitions
  • 1.2.1. Type
  • 1.2.2. Application
  • 1.2.3. End User
• 1.3. Information analysis
• 1.4. Market formulation & data visualization
• 1.5. Data validation & publishing
• 1.6. Information Procurement
  • 1.6.1. Primary Research
• 1.7. Information or Data Analysis
• 1.8. Market Formulation & Validation
• 1.9. Market Model
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Ancillary Market Outlook
• 3.2. Market Trends and Outlook
• 3.3. Market Dynamics
  • 3.3.1. Market Driver Impact Analysis
    • 3.3.1.1. Increasing demand for continuous and high-yield bioprocessing
    • 3.3.1.2. Rising production of biologics
    • 3.3.1.3. Growth in the cell and gene therapy pipeline
  • 3.3.2. Market Restraint Impact Analysis
    • 3.3.2.1. Limited standardization of perfusion processes
    • 3.3.2.2. Stringent regulatory validation and compliance requirements
  • 3.3.3. Market Challenges Analysis
  • 3.3.4. Market Opportunity Analysis
• 3.4. Case Study Insights
• 3.5. Business Environment Analysis
  • 3.5.1. PESTLE Analysis
  • 3.5.2. PORTER'S Five Forces Analysis

Chapter 4. Type Business Analysis

• 4.1. Type Segment Dashboard
• 4.2. Global Perfusion Bioreactors Market Type, Movement Analysis
• 4.3. Global Perfusion Bioreactors Market Size & Trend Analysis, by Type, 2021 to 2033 (USD Million)
• 4.4. Small Scale Perfusion Bioreactors
  • 4.4.1. Global small scale perfusion bioreactors market estimates and forecasts, 2021 - 2033 (USD Million)
• 4.5. Large Scale Perfusion Bioreactors
  • 4.5.1. Global large scale perfusion bioreactors market estimates and forecasts, 2021 - 2033 (USD million)

Chapter 5. Application Business Analysis

• 5.1. Application Segment Dashboard
• 5.2. Global Perfusion Bioreactors Market Application, Movement Analysis
• 5.3. Global Perfusion Bioreactors Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
• 5.4. Biopharmaceutical Production
  • 5.4.1. Global biopharmaceutical production market estimates and forecasts, 2021 - 2033 (USD million)
• 5.5. Tissue Engineering
  • 5.5.1. Global tissue engineering market estimates and forecasts, 2021 - 2033 (USD million)
• 5.6. Stem Cell Research
  • 5.6.1. Global stem cell research market estimates and forecasts, 2021 - 2033 (USD million)
• 5.7. Others
  • 5.7.1. Global Others market estimates and forecasts, 2021 - 2033 (USD million)

Chapter 6. End Use Business Analysis

• 6.1. End Use Segment Dashboard
• 6.2. Global Perfusion Bioreactors Market End Use, Movement Analysis
• 6.3. Global Perfusion Bioreactors Market Size & Trend Analysis, by End User, 2021 to 2033 (USD Million)
• 6.4. Biopharmaceutical Companies
  • 6.4.1. Global biopharmaceutical companies market estimates and forecasts, 2021 - 2033 (USD million)
• 6.5. Academic and Research Institutes
  • 6.5.1. Global academic and research institutes market estimates and forecasts, 2021 - 2033 (USD million)
• 6.6. CROs & CMOs
  • 6.6.1. Global CROs & CMOs market estimates and forecasts, 2021 - 2033 (USD million)

Chapter 7. Perfusion Bioreactors Market: Regional Estimates and Trend Analysis, by Type, Application & End Use

• 7.1. Regional Dashboard
• 7.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
• 7.3. North America
  • 7.3.1. North America Perfusion Bioreactors Market, 2021 - 2033 (USD Million)
  • 7.3.2. U.S.
    • 7.3.2.1. Key Country Dynamics
    • 7.3.2.2. Competitive Scenario
    • 7.3.2.3. Regulatory Framework
    • 7.3.2.4. U.S. Perfusion Bioreactors Market, 2021 - 2033 (USD Million)
  • 7.3.3. Canada
    • 7.3.3.1. Key Country Dynamics
    • 7.3.3.2. Competitive Scenario
    • 7.3.3.3. Regulatory Framework
    • 7.3.3.4. Canada Perfusion Bioreactors Market, 2021 - 2033 (USD Million)
  • 7.3.4. Mexico
    • 7.3.4.1. Key Country Dynamics
    • 7.3.4.2. Competitive Scenario
    • 7.3.4.3. Regulatory Framework
    • 7.3.4.4. Mexico Perfusion Bioreactors Market, 2021 - 2033 (USD Million)
• 7.4. Europe
  • 7.4.1. Europe Perfusion Bioreactors Market, 2021 - 2033 (USD Million)
  • 7.4.2. UK
    • 7.4.2.1. Key Country Dynamics
    • 7.4.2.2. Competitive Scenario
    • 7.4.2.3. Regulatory Framework
    • 7.4.2.4. UK Perfusion Bioreactors Market, 2021 - 2033 (USD Million)
  • 7.4.3. Germany
    • 7.4.3.1. Key Country Dynamics
    • 7.4.3.2. Competitive Scenario
    • 7.4.3.3. Regulatory Framework
    • 7.4.3.4. Germany Perfusion Bioreactors Market, 2021 - 2033 (USD Million)
  • 7.4.4. France
    • 7.4.4.1. Key Country Dynamics
    • 7.4.4.2. Competitive Scenario
    • 7.4.4.3. Regulatory Framework
    • 7.4.4.4. France Perfusion Bioreactors Market, 2021 - 2033 (USD Million)
  • 7.4.5. Italy
    • 7.4.5.1. Key Country Dynamics
    • 7.4.5.2. Competitive Scenario
    • 7.4.5.3. Regulatory Framework
    • 7.4.5.4. Italy Perfusion Bioreactors Market, 2021 - 2033 (USD Million)
  • 7.4.6. Spain
    • 7.4.6.1. Key Country Dynamics
    • 7.4.6.2. Competitive Scenario
    • 7.4.6.3. Regulatory Framework
    • 7.4.6.4. Spain Perfusion Bioreactors Market, 2021 - 2033 (USD Million)
  • 7.4.7. Denmark
    • 7.4.7.1. Key Country Dynamics
    • 7.4.7.2. Competitive Scenario
    • 7.4.7.3. Regulatory Framework
    • 7.4.7.4. Denmark Perfusion Bioreactors Market, 2021 - 2033 (USD Million)
  • 7.4.8. Sweden
    • 7.4.8.1. Key Country Dynamics
    • 7.4.8.2. Competitive Scenario
    • 7.4.8.3. Regulatory Framework
    • 7.4.8.4. Sweden Perfusion Bioreactors Market, 2021 - 2033 (USD Million)
  • 7.4.9. Norway
    • 7.4.9.1. Key Country Dynamics
    • 7.4.9.2. Competitive Scenario
    • 7.4.9.3. Regulatory Framework
    • 7.4.9.4. Norway Perfusion Bioreactors Market, 2021 - 2033 (USD Million)
• 7.5. Asia Pacific
  • 7.5.1. Asia Pacific Perfusion Bioreactors Market, 2021 - 2033 (USD Million)
  • 7.5.2. Japan
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Competitive Scenario
    • 7.5.2.3. Regulatory Framework
    • 7.5.2.4. Japan Perfusion Bioreactors Market, 2021 - 2033 (USD Million)
  • 7.5.3. China
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Competitive Scenario
    • 7.5.3.3. Regulatory Framework
    • 7.5.3.4. China Perfusion Bioreactors Market, 2021 - 2033 (USD Million)
  • 7.5.4. India
    • 7.5.4.1. Key Country Dynamics
    • 7.5.4.2. Competitive Scenario
    • 7.5.4.3. Regulatory Framework
    • 7.5.4.4. India Perfusion Bioreactors Market, 2021 - 2033 (USD Million)
  • 7.5.5. Singapore
    • 7.5.5.1. Key Country Dynamics
    • 7.5.5.2. Competitive Scenario
    • 7.5.5.3. Regulatory Framework
    • 7.5.5.4. Singapore Perfusion Bioreactors Market, 2021 - 2033 (USD Million)
  • 7.5.6. Australia
    • 7.5.6.1. Key Country Dynamics
    • 7.5.6.2. Competitive Scenario
    • 7.5.6.3. Regulatory Framework
    • 7.5.6.4. Australia Perfusion Bioreactors Market, 2021 - 2033 (USD Million)
  • 7.5.7. Thailand
    • 7.5.7.1. Key Country Dynamics
    • 7.5.7.2. Competitive Scenario
    • 7.5.7.3. Regulatory Framework
    • 7.5.7.4. Thailand Perfusion Bioreactors Market, 2021 - 2033 (USD Million)
  • 7.5.8. South Korea
    • 7.5.8.1. Key Country Dynamics
    • 7.5.8.2. Competitive Scenario
    • 7.5.8.3. Regulatory Framework
    • 7.5.8.4. South Korea Perfusion Bioreactors Market, 2021 - 2033 (USD Million)
• 7.6. Latin America
  • 7.6.1. Latin America Perfusion Bioreactors Market, 2021 - 2033 (USD Million)
  • 7.6.2. Brazil
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Competitive Scenario
    • 7.6.2.3. Regulatory Framework
    • 7.6.2.4. Brazil Perfusion Bioreactors Market, 2021 - 2033 (USD Million)
  • 7.6.3. Argentina
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Competitive Scenario
    • 7.6.3.3. Regulatory Framework
    • 7.6.3.4. Argentina Perfusion Bioreactors Market, 2021 - 2033 (USD Million)
• 7.7. MEA
  • 7.7.1. MEA Perfusion Bioreactors Market, 2021 - 2033 (USD Million)
  • 7.7.2. South Africa
    • 7.7.2.1. Key Country Dynamics
    • 7.7.2.2. Competitive Scenario
    • 7.7.2.3. Regulatory Framework
    • 7.7.2.4. South Africa Perfusion Bioreactors Market, 2021 - 2033 (USD Million)
  • 7.7.3. Saudi Arabia
    • 7.7.3.1. Key Country Dynamics
    • 7.7.3.2. Competitive Scenario
    • 7.7.3.3. Regulatory Framework
    • 7.7.3.4. Saudi Arabia Perfusion Bioreactors Market, 2021 - 2033 (USD Million)
  • 7.7.4. UAE
    • 7.7.4.1. Key Country Dynamics
    • 7.7.4.2. Competitive Scenario
    • 7.7.4.3. Regulatory Framework
    • 7.7.4.4. UAE Perfusion Bioreactors Market, 2021 - 2033 (USD Million)
  • 7.7.5. Kuwait
    • 7.7.5.1. Key Country Dynamics
    • 7.7.5.2. Competitive Scenario
    • 7.7.5.3. Regulatory Framework
    • 7.7.5.4. Kuwait Perfusion Bioreactors Market, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Company Categorization
• 8.2. Strategy Mapping
• 8.3. Company Market Position Analysis, 2025
• 8.4. Company Profiles/Listing
  • 8.4.1. Sartorius AG
    • 8.4.1.1. Overview
    • 8.4.1.2. Financial Performance
    • 8.4.1.3. Product Benchmarking
    • 8.4.1.4. Strategic Initiatives
  • 8.4.2. Cell Culture Company
    • 8.4.2.1. Overview
    • 8.4.2.2. Financial Performance
    • 8.4.2.3. Product Benchmarking
    • 8.4.2.4. Strategic Initiatives
  • 8.4.3. Cytiva (Danaher Corporation)
    • 8.4.3.1. Overview
    • 8.4.3.2. Financial Performance
    • 8.4.3.3. Product Benchmarking
    • 8.4.3.4. Strategic Initiatives
  • 8.4.4. CELLEC BIOTEK AG
    • 8.4.4.1. Overview
    • 8.4.4.2. Financial Performance
    • 8.4.4.3. Product Benchmarking
    • 8.4.4.4. Strategic Initiatives
  • 8.4.5. Synthecon Inc.
    • 8.4.5.1. Overview
    • 8.4.5.2. Financial Performance
    • 8.4.5.3. Product Benchmarking
    • 8.4.5.4. Strategic Initiatives
  • 8.4.6. Getinge (Applikon Biotechnology B.V)
    • 8.4.6.1. Overview
    • 8.4.6.2. Financial Performance
    • 8.4.6.3. Product Benchmarking
    • 8.4.6.4. Strategic Initiatives
  • 8.4.7. Zellwerk GmbH
    • 8.4.7.1. Overview
    • 8.4.7.2. Financial Performance
    • 8.4.7.3. Product Benchmarking
    • 8.4.7.4. Strategic Initiatives
  • 8.4.8. Thermo Fisher Scientific Inc.
    • 8.4.8.1. Overview
    • 8.4.8.2. Financial Performance
    • 8.4.8.3. Product Benchmarking
    • 8.4.8.4. Strategic Initiatives
  • 8.4.9. Eppendorf AG
    • 8.4.9.1. Overview
    • 8.4.9.2. Financial Performance
    • 8.4.9.3. Product Benchmarking
    • 8.4.9.4. Strategic Initiatives
  • 8.4.10. Infors HT
    • 8.4.10.1. Overview
    • 8.4.10.2. Financial Performance
    • 8.4.10.3. Product Benchmarking
    • 8.4.10.4. Strategic Initiatives
  • 8.4.11. 3D Biotek LLC
    • 8.4.11.1. Overview
    • 8.4.11.2. Financial Performance
    • 8.4.11.3. Product Benchmarking
    • 8.4.11.4. Strategic Initiatives